Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|June 6, 2025
Efficacy of tocilizumab monotherapy after ultrashort glucocorticoid administration to treat giant cell arteritis: three-year follow-upLisa Christ, Luca Seitz, Godehard Scholz, et al.
Frontiers in Radiology|July 16, 2025
2D-cranial T1-black-blood MRI in suspected giant cell arteritis-measurement of vessel wall thickness does not give a diagnostic advantage compared to visual scoring alonePascal Seitz, Susana Bucher, Lukas Bütikofer, et al.
Pain|October 9, 2020
Cold pain hypersensitivity predicts trajectories of pain and disability after low back surgery: a prospective cohort studyMonika Müller, Lukas Bütikofer, Ole K Andersen, et al.
Rheumatology (Oxford, England)|August 9, 2023
Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis: a comparison with T1-weighted black-blood imagingLuca Seitz, Susana Bucher, Lukas Bütikofer, et al.
Rheumatology (Oxford, England)|July 22, 2024
Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumabLisa Christ, Harald M Bonel, Jennifer L Cullmann, et al.
Plos One|August 9, 2023
Factors associated with one-year mortality after hospital discharge: A multicenter prospective cohort studyFabian D Liechti, Lukas Bütikofer, Marco Mancinetti, et al.
Rheumatology (Oxford, England)|March 13, 2018
Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritisStephan Reichenbach, Sabine Adler, Harald Bonel, et al.
Journal of General Internal Medicine|December 13, 2023
The Early HOSPITAL Score to Predict 30-Day Readmission Soon After Hospitalization: a Prospective Multicenter StudyPhilippe Mathys, Lukas Bütikofer, Daniel Genné, et al.
JAMA Internal Medicine|May 1, 2023
Effects of a Multimodal Transitional Care Intervention in Patients at High Risk of Readmission: The TARGET-READ Randomized Clinical TrialJacques Donzé, Gregor John, Daniel Genné, et al.
Lancet (London, England)|March 9, 2016
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialPeter M Villiger, Sabine Adler, Stefan Kuchen, et al.
Pageof 6